Saturday, September 12, 2026

Treatment of Bell's Palsy

Treatment of Bell's Palsy - Clinical Lecture Notes

Treatment of Bell's Palsy

Clinical Lecture Notes


1. Corticosteroid Therapy (First-Line Standard of Care)

  • Timing: Initiate oral corticosteroids within 72 hours of symptom onset to maximize facial nerve recovery.
  • Population differences:
    • Adults: Significantly increases the rate and likelihood of complete facial nerve functional recovery.
    • Pediatric patients: Routine corticosteroids show no significant benefit, as the majority of children achieve complete spontaneous recovery without treatment.
  • Standard adult dosing regimens:
    • Prednisolone 25 mg PO twice daily for 10 days, or
    • Prednisone / Prednisolone 60 mg PO daily for 5 days, followed by a 5-day taper over the subsequent 5 days.

2. Role of Antivirals

  • Ineffective as monotherapy:
    • Antiviral monotherapy (acyclovir, valacyclovir, or famciclovir) is ineffective and should never be prescribed alone.
  • Clinical utility of combination therapy (Steroids + Antivirals):
    • Across unselected populations, adding antivirals provides modest improvement in overall recovery rates.
    • Significantly reduces long-term sequelae, notably motor synkinesis, crocodile tears (gustatory lacrimation), and permanent residual deficit.
  • Specific indications for adding antiviral therapy:
    • Severe initial paralysis: House-Brackmann grade V or VI presentation.
    • Intense otalgia or presentation suspicious for herpes zoster sine herpete.
    • Confirmed varicella-zoster virus (Ramsay Hunt syndrome; mandatory antiviral indication).
  • Recommended combination regimen:
    • Famciclovir 750 mg PO daily for 7 days (or 250 mg PO TID for 7 days).
    • High-dose tapered corticosteroid: Prednisolone 80 mg PO daily tapered over 12 days (or 1 mg/kg/day in lower-weight adults).
    • Evidence profile: Network meta-analyses indicate famciclovir achieves a higher probability of recovery compared to other antiviral agents.

3. Eye Protection and Supportive Measures

  • Prevention of exposure keratopathy:
    • Incomplete eyelid closure (lagophthalmos) risks corneal abrasion, ulceration, and permanent visual loss.
  • Comprehensive corneal protection bundle:
    • Daytime: Frequent instillation of preservative-free lubricating artificial tears.
    • Bedtime: Preservative-free lubricating ophthalmic ointment.
    • Nighttime: Moisture-retaining eye chambers or protective shields, or careful taping of the upper eyelid closed.
  • Adjunctive therapies:
    • Physical therapy to promote neuromuscular coordination during reinnervation.
    • Botulinum toxin injections for management of delayed motor synkinesis or severe resting asymmetry.

4. Specialist Referral and Red Flags

  • Triggers for immediate otolaryngology (ENT) or neurology consultation:
    • Absence of clinical improvement after 3 months from onset.
    • Bilateral facial weakness (mandates evaluation for Lyme disease, Guillain-Barre syndrome, or sarcoidosis).
    • Recurrent episodes of facial paralysis.
  • Long-term intervention:
    • Consideration of static or dynamic facial reanimation surgery for patients with persistent, disfiguring functional deficits.

5. Summary Takeaway

Oral corticosteroids initiated within 72 hours are the definitive first-line therapy for adult Bell's palsy. For patients with severe palsy (House-Brackmann grade V or VI) or zoster features, add famciclovir 750 mg daily for 7 days to high-dose tapered corticosteroids. Corneal protection via daytime tears, nighttime ointment, and nocturnal occlusion is mandatory for all patients with impaired eyelid closure.


Clinical Lecture Notes - Emergency and Acute Care Neurology Reference

Diabetic Ketoacidosis Management

Diabetic Ketoacidosis: Treat Ketones, Not Just Glucose Diabetic Ketoacidosis: Treat Ketones, Not Just Glucose Diagnostic...